Literature DB >> 8673727

Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics.

K M Kelley1, Y Oh, S E Gargosky, Z Gucev, T Matsumoto, V Hwa, L Ng, D M Simpson, R G Rosenfeld.   

Abstract

The IGFBPs are a family of homologous proteins that have co-evolved with the IGFs and that confer upon the IGF regulatory system both functional and tissue specificity. IGFBPs are not merely carrier proteins for IGFs, but hold a central position in IGF ligand-receptor interactions through influences on both the bioavailability and distribution of IGFs in the extracellular environment. In addition, IGFBPs appear to have intrinsic biological activity independent of IGFs. The current status of research on IGFBPs is reviewed herein. Following a brief introduction to the entire IGF/IGFBP system, separate sections for each of the six cloned mammalian IGFBPs, the most extensive for IGFBP3, cover selected topics that emphasize the dynamics of IGFBPs--that is, their regulation in cells, their functionally important post-translational modifications, and their interactions in the cellular microenvironment--and how these dynamics influence physiological function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8673727     DOI: 10.1016/1357-2725(96)00005-2

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  103 in total

Review 1.  Cellular actions of insulin-like growth factor binding proteins.

Authors:  R J Ferry; L E Katz; A Grimberg; P Cohen; S A Weinzimer
Journal:  Horm Metab Res       Date:  1999 Feb-Mar       Impact factor: 2.936

Review 2.  Genetics, chemistry, and function of the IGF/IGFBP system.

Authors:  P F Collett-Solberg; P Cohen
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.633

3.  IGFBP-3, a marker of cellular senescence, is overexpressed in human papillomavirus-immortalized cervical cells and enhances IGF-1-induced mitogenesis.

Authors:  Astrid C Baege; Gary L Disbrow; Richard Schlegel
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  Deletion of muscle GRP94 impairs both muscle and body growth by inhibiting local IGF production.

Authors:  Elisabeth R Barton; SooHyun Park; Jose K James; Catherine A Makarewich; Anastassios Philippou; Davide Eletto; Hanqin Lei; Becky Brisson; Olga Ostrovsky; Zihai Li; Yair Argon
Journal:  FASEB J       Date:  2012-05-30       Impact factor: 5.191

Review 5.  The insulin-like growth factor system and colorectal cancer: clinical and experimental evidence.

Authors:  M Davies; S Gupta; G Goldspink; M Winslet
Journal:  Int J Colorectal Dis       Date:  2005-06-16       Impact factor: 2.571

6.  Differential expression of IGF components and insulin receptor isoforms in human seminoma versus normal testicular tissue.

Authors:  Tanja Pascale Neuvians; Isabella Gashaw; Andrea Hasenfus; Axel Hacherhäcker; Elke Winterhager; Rainer Grobholz
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

7.  Role of insulin-like growth factor binding proteins (IGFBPs) in breast cancer proliferation and metastasis.

Authors:  Erin D Giles; Gurmit Singh
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

8.  Rexinoid-induced expression of IGFBP-6 requires RARbeta-dependent permissive cooperation of retinoid receptors and AP-1.

Authors:  Iván P Uray; Qiang Shen; Hye-Sook Seo; HeeTae Kim; William W Lamph; Reid P Bissonnette; Powel H Brown
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

Review 9.  Insulin: a novel agent in the pathogenesis of prostate cancer.

Authors:  Hanumanthappa Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-07-30       Impact factor: 2.370

10.  The impact of IGF-I gene polymorphisms on coronary artery disease susceptibility.

Authors:  Hsiu-Ling Lin; Kwo-Chang Ueng; Hsiang-Ling Wang; Tsung-Po Chen; Shun-Fa Yang; Shu-Chen Chu; Yih-Shou Hsieh
Journal:  J Clin Lab Anal       Date:  2013-02-19       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.